"Ibogaine: A Promising Psychedelic for Healing Traumatic Brain Injury and PTSD"

A small study has shown that a single dose of the psychedelic drug ibogaine, combined with magnesium, significantly improved symptoms of depression, anxiety, PTSD, and cognitive functions in military veterans with traumatic brain injuries (TBIs). The research, which involved 30 special ops veterans, suggests that ibogaine may interact with various neurotransmitter systems and support brain cell growth and rewiring. Despite ibogaine being a Schedule I controlled substance in the U.S., the positive findings from the study, published in Nature Medicine, indicate the need for larger, double-blind, placebo-controlled clinical trials to further investigate its potential as a therapeutic drug for TBI and other neuropsychiatric conditions.